Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberCN101631464 A
Publication typeApplication
Application numberCN 200780044849
PCT numberPCT/US2007/024985
Publication date20 Jan 2010
Filing date5 Dec 2007
Priority date5 Dec 2006
Also published asCA2671614A1, CA2671614C, CN105254634A, EP2096919A1, EP2096919A4, EP2096919B1, US8466283, US20110083984, US20130261113, WO2008070150A1
Publication number200780044849.7, CN 101631464 A, CN 101631464A, CN 200780044849, CN-A-101631464, CN101631464 A, CN101631464A, CN200780044849, CN200780044849.7, PCT/2007/24985, PCT/US/2007/024985, PCT/US/2007/24985, PCT/US/7/024985, PCT/US/7/24985, PCT/US2007/024985, PCT/US2007/24985, PCT/US2007024985, PCT/US200724985, PCT/US7/024985, PCT/US7/24985, PCT/US7024985, PCT/US724985
InventorsM亨特曼, J伍德, W斯科特, M米歇尔斯, A-M坎贝尔, A-M比利翁, RB罗利, A雷德曼
Applicant拜耳先灵医药股份有限公司
Export CitationBiBTeX, EndNote, RefMan
External Links: SIPO, Espacenet
用于治疗过度增殖疾病和血管发生相关性疾病的2,3-二氢咪唑并[1,2-c]喹唑啉取代衍生物
CN 101631464 A
Description  available in Chinese
Claims(44)  available in Chinese
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
CN102906094A *8 Nov 201130 Jan 2013拜耳知识产权有限责任公司用于治疗过度增殖性病症和与血管发生相关的疾病的氨基醇取代的2,3-二氢咪唑并[1,2-c]喹唑啉衍生物
CN103214489A *25 Feb 201324 Jul 2013中国人民解放军第二军医大学一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法
CN103214489B *25 Feb 201326 Oct 2016中国人民解放军第二军医大学一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法
CN103339133A *8 Nov 20112 Oct 2013拜耳知识产权有限责任公司烷氧基取代的2,3-二氢咪唑并[1,2-c]喹唑啉
CN103339133B *8 Nov 201115 Jun 2016拜耳知识产权有限责任公司烷氧基取代的2,3-二氢咪唑并[1,2-c]喹唑啉
CN103370320A *8 Nov 201123 Oct 2013拜耳知识产权有限责任公司芳基氨基醇取代的2,3-二氢咪唑并[1,2-c]喹啉
CN103370320B *8 Nov 201127 Apr 2016拜耳知识产权有限责任公司芳基氨基醇取代的2,3-二氢咪唑并[1,2-c]喹啉
CN103608018A *29 Mar 201226 Feb 2014拜耳知识产权有限责任公司取代的2,3-二氢咪唑并[1,2-c]喹唑啉的用途
CN103649091A *29 Mar 201219 Mar 2014拜耳知识产权有限责任公司取代的2,3-二氢咪唑并[1,2-c]喹唑啉盐
CN103649091B *29 Mar 201222 Jun 2016拜耳知识产权有限责任公司取代的2,3-二氢咪唑并[1,2-c]喹唑啉盐
CN104557955A *23 Oct 201329 Apr 2015上海汇伦生命科技有限公司作为PI3K/mTOR抑制剂的三环类化合物,其制备方法和用途
CN104557955B *23 Oct 20133 May 2017上海汇伦生命科技有限公司作为PI3K/mTOR抑制剂的三环类化合物,其制备方法和用途
CN104582732A *14 Jun 201329 Apr 2015布里格姆及妇女医院股份有限公司治疗癌症的组合物及其制造方法
CN105130997A *25 Sep 20159 Dec 2015苏州明锐医药科技有限公司一种库潘尼西的制备方法
CN105263497A *4 Apr 201420 Jan 2016拜耳制药股份公司取代的2,3-二氢咪唑并[1,2-c]喹唑啉治疗淋巴瘤的用途
WO2017049983A1 *1 Jul 201630 Mar 2017苏州立新制药有限公司库潘尼西的制备方法
Classifications
International ClassificationA01N43/54
Cooperative ClassificationA01N43/90, A61K31/519, C07D487/04, A61K31/5377
European ClassificationA01N43/90, C07D487/04
Legal Events
DateCodeEventDescription
20 Jan 2010C06Publication
24 Mar 2010C10Entry into substantive examination
30 Sep 2010REGReference to a national code
Ref country code: HK
Ref legal event code: DE
Ref document number: 1139839
Country of ref document: HK
28 Aug 2013C53Correction of patent for invention or patent application
28 Aug 2013CORChange of bibliographic data
Free format text: CORRECT: APPLICANT; FROM: SCHERING AG TO: BAYER PHARMA AG
28 Aug 2013ASSSuccession or assignment of patent right
Owner name: BAYER INTELLECTUAL PROPERTY GMBH
Free format text: FORMER OWNER: BAYER PHARMA AG
Effective date: 20130805
28 Aug 2013C41Transfer of patent application or patent right or utility model